Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84+0.01 (+0.97%)
Close on Nov 17, 2026Market cap $13.95MP/E –Yield –
Marker Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Marker Therapeutics's price to book ratio was 1.3× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.3× to 4.2×, with a median of 1.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | −0.0 |
| 2025 | Dec 31, 2025 | 1.4× | −2.4 |
| 2024 | Dec 31, 2024 | 3.7× | +0.8 |
| 2023 | Dec 29, 2023 | 2.9× | +1.9 |
| 2022 | Dec 30, 2022 | 1.0× | −0.5 |
| 2021 | Dec 31, 2021 | 1.5× | −0.8 |
| 2020 | Dec 31, 2020 | 2.3× | −0.5 |
| 2019 | Dec 31, 2019 | 2.7× | −15.5 |
| 2018 | Dec 31, 2018 | 18.2× | +11.3 |
| 2017 | Dec 29, 2017 | 6.9× | +2.6 |
| 2016 | Dec 30, 2016 | 4.3× | – |
See a number that looks wrong?